| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial.
|
Eur Heart J
|
2008
|
4.42
|
|
2
|
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
|
Eur Heart J
|
2004
|
3.19
|
|
3
|
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations.
|
J Cardiovasc Magn Reson
|
2009
|
3.17
|
|
4
|
Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction.
|
J Am Coll Cardiol
|
2003
|
2.78
|
|
5
|
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
|
Eur Heart J
|
2010
|
2.62
|
|
6
|
Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study.
|
Eur Heart J
|
2007
|
2.46
|
|
7
|
Standardizing the definition of hyperenhancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR.
|
J Cardiovasc Magn Reson
|
2005
|
2.27
|
|
8
|
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase.
|
J Am Coll Cardiol
|
2009
|
2.23
|
|
9
|
Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
|
Eur Heart J
|
2006
|
2.12
|
|
10
|
Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology.
|
Eur Heart J
|
2004
|
1.77
|
|
11
|
Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction.
|
JACC Cardiovasc Imaging
|
2009
|
1.68
|
|
12
|
Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
1.66
|
|
13
|
Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
|
J Am Coll Cardiol
|
2006
|
1.63
|
|
14
|
Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging.
|
Radiology
|
2005
|
1.62
|
|
15
|
Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function.
|
J Am Coll Cardiol
|
2006
|
1.59
|
|
16
|
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction.
|
J Am Coll Cardiol
|
2008
|
1.58
|
|
17
|
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
|
Catheter Cardiovasc Interv
|
2008
|
1.58
|
|
18
|
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report.
|
J Cardiovasc Magn Reson
|
2004
|
1.54
|
|
19
|
Quantitative relationship between coronary artery calcium score and hyperemic myocardial blood flow as assessed by hybrid 15O-water PET/CT imaging in patients evaluated for coronary artery disease.
|
J Nucl Cardiol
|
2011
|
1.54
|
|
20
|
Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury.
|
J Am Coll Cardiol
|
2008
|
1.50
|
|
21
|
Left ventricular thrombus formation after acute myocardial infarction as assessed by cardiovascular magnetic resonance imaging.
|
Eur J Radiol
|
2012
|
1.47
|
|
22
|
Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
|
JACC Cardiovasc Imaging
|
2009
|
1.47
|
|
23
|
Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study.
|
EuroIntervention
|
2015
|
1.47
|
|
24
|
Combined non-invasive functional and anatomical diagnostic work-up in clinical practice: the magnetic resonance and computed tomography in suspected coronary artery disease (MARCC) study.
|
Eur Heart J
|
2013
|
1.44
|
|
25
|
Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome.
|
J Cardiovasc Magn Reson
|
2009
|
1.43
|
|
26
|
Low to intermediate probability of coronary artery disease: comparison of coronary CT angiography with first-pass MR myocardial perfusion imaging.
|
Radiology
|
2010
|
1.42
|
|
27
|
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction: the EXAMI study.
|
Int J Cardiol
|
2012
|
1.41
|
|
28
|
Measurement of left ventricular volumes and function with O-15-labeled carbon monoxide gated positron emission tomography: comparison with magnetic resonance imaging.
|
J Nucl Cardiol
|
2005
|
1.41
|
|
29
|
Prediction of long-term outcome of cardiac resynchronization therapy by acute pressure-volume loop measurements.
|
Eur J Heart Fail
|
2012
|
1.41
|
|
30
|
Myocardial infarct heterogeneity assessment by late gadolinium enhancement cardiovascular magnetic resonance imaging shows predictive value for ventricular arrhythmia development after acute myocardial infarction.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
1.38
|
|
31
|
Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models.
|
Heart
|
2011
|
1.35
|
|
32
|
Motives for (not) participating in a lifestyle intervention trial.
|
BMC Med Res Methodol
|
2008
|
1.33
|
|
33
|
Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study.
|
Circ Cardiovasc Imaging
|
2011
|
1.32
|
|
34
|
Extent of MRI delayed enhancement of myocardial mass is related to right ventricular dysfunction in pulmonary artery hypertension.
|
AJR Am J Roentgenol
|
2007
|
1.28
|
|
35
|
Coronary microvascular resistance: methods for its quantification in humans.
|
Basic Res Cardiol
|
2009
|
1.26
|
|
36
|
Assessment of microvascular obstruction and prediction of short-term remodeling after acute myocardial infarction: cardiac MR imaging study.
|
Radiology
|
2009
|
1.19
|
|
37
|
Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging.
|
J Am Coll Cardiol
|
2004
|
1.19
|
|
38
|
Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
|
Circulation
|
2005
|
1.18
|
|
39
|
Clinical applications of cardiovascular magnetic resonance imaging.
|
CMAJ
|
2006
|
1.14
|
|
40
|
Semi-quantitative assessment of right ventricular function in comparison to a 3D volumetric approach: a cardiovascular magnetic resonance study.
|
Eur Radiol
|
2008
|
1.13
|
|
41
|
Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.
|
Eur Heart J
|
2013
|
1.11
|
|
42
|
Three-dimensional speckle tracking echocardiography for automatic assessment of global and regional left ventricular function based on area strain.
|
J Am Soc Echocardiogr
|
2011
|
1.11
|
|
43
|
Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
1.09
|
|
44
|
Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
|
J Cardiovasc Magn Reson
|
2007
|
1.09
|
|
45
|
Feature tracking compared with tissue tagging measurements of segmental strain by cardiovascular magnetic resonance.
|
J Cardiovasc Magn Reson
|
2014
|
1.08
|
|
46
|
Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy.
|
Am J Physiol Heart Circ Physiol
|
2007
|
1.07
|
|
47
|
Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography.
|
J Am Coll Cardiol
|
2003
|
1.05
|
|
48
|
Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study.
|
Eur Heart J
|
2008
|
1.04
|
|
49
|
Current variables, definitions and endpoints of the European cardiovascular magnetic resonance registry.
|
J Cardiovasc Magn Reson
|
2009
|
1.02
|
|
50
|
Mechanical dyssynchrony or myocardial shortening as MRI predictor of response to biventricular pacing?
|
J Magn Reson Imaging
|
2007
|
1.01
|
|
51
|
A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: monocytes and myocardial infarction.
|
Am Heart J
|
2011
|
1.01
|
|
52
|
Myocardial viability: rapid assessment with delayed contrast-enhanced MR imaging with three-dimensional inversion-recovery prepared pulse sequence.
|
Radiology
|
2003
|
1.00
|
|
53
|
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
|
Am Heart J
|
2006
|
1.00
|
|
54
|
T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions.
|
Circ Cardiovasc Imaging
|
2012
|
0.99
|
|
55
|
Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness.
|
J Cardiovasc Magn Reson
|
2011
|
0.99
|
|
56
|
DENSE and HARP: two views on the same technique of phase-based strain imaging.
|
J Magn Reson Imaging
|
2006
|
0.98
|
|
57
|
Sequence optimization to reduce velocity offsets in cardiovascular magnetic resonance volume flow quantification--a multi-vendor study.
|
J Cardiovasc Magn Reson
|
2011
|
0.98
|
|
58
|
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
|
J Cardiovasc Magn Reson
|
2009
|
0.97
|
|
59
|
Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study.
|
Eur J Nucl Med Mol Imaging
|
2011
|
0.97
|
|
60
|
Reliability of left ventricular volumes and function measurements using three-dimensional speckle tracking echocardiography.
|
Eur Heart J Cardiovasc Imaging
|
2011
|
0.96
|
|
61
|
How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance.
|
J Cardiovasc Magn Reson
|
2010
|
0.96
|
|
62
|
Does myocardial fibrosis hinder contractile function and perfusion in idiopathic dilated cardiomyopathy? PET and MR imaging study.
|
Radiology
|
2006
|
0.95
|
|
63
|
Effects of aging on left atrioventricular coupling and left ventricular filling assessed using cardiac magnetic resonance imaging in healthy subjects.
|
Am J Cardiol
|
2007
|
0.95
|
|
64
|
Three-dimensional myocardial strains at end-systole and during diastole in the left ventricle of normal humans.
|
J Cardiovasc Magn Reson
|
2002
|
0.95
|
|
65
|
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
|
Cardiovasc Drugs Ther
|
2012
|
0.94
|
|
66
|
Hybrid imaging using quantitative H215O PET and CT-based coronary angiography for the detection of coronary artery disease.
|
J Nucl Med
|
2012
|
0.93
|
|
67
|
Improved correction of spatial inhomogeneities of surface coils in quantitative analysis of first-pass myocardial perfusion imaging.
|
J Magn Reson Imaging
|
2010
|
0.92
|
|
68
|
Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunction.
|
Eur J Heart Fail
|
2011
|
0.92
|
|
69
|
Propagation of onset and peak time of myocardial shortening in time of myocardial shortening in ischemic versus nonischemic cardiomyopathy: assessment by magnetic resonance imaging myocardial tagging.
|
J Am Coll Cardiol
|
2005
|
0.91
|
|
70
|
Quantitative comparison of 2D and 3D circumferential strain using MRI tagging in normal and LBBB hearts.
|
Magn Reson Med
|
2007
|
0.91
|
|
71
|
Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with (15)O-labeled water and positron emission tomography.
|
J Nucl Cardiol
|
2011
|
0.89
|
|
72
|
In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
|
J Cardiovasc Magn Reson
|
2014
|
0.88
|
|
73
|
Quality assessment of cardiovascular magnetic resonance in the setting of the European CMR registry: description and validation of standardized criteria.
|
J Cardiovasc Magn Reson
|
2013
|
0.87
|
|
74
|
Delayed contrast-enhanced magnetic resonance imaging in pulmonary arterial hypertension.
|
Circulation
|
2005
|
0.87
|
|
75
|
Pathological Q waves in myocardial infarction in patients treated by primary PCI.
|
JACC Cardiovasc Imaging
|
2013
|
0.86
|
|
76
|
Comparison of dual to single contrast bolus magnetic resonance myocardial perfusion imaging for detection of significant coronary artery disease.
|
J Magn Reson Imaging
|
2010
|
0.86
|
|
77
|
Comparison between direct volumetric and speckle tracking methodologies for left ventricular and left atrial chamber quantification by three-dimensional echocardiography.
|
Am J Cardiol
|
2011
|
0.85
|
|
78
|
SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility.
|
PLoS One
|
2012
|
0.85
|
|
79
|
Chagas' heart disease diagnosed on MRI: the importance of patient "geographic" history.
|
Int J Cardiol
|
2007
|
0.85
|
|
80
|
Loss of opposite left ventricular basal and apical rotation predicts acute response to cardiac resynchronization therapy and is associated with long-term reversed remodeling.
|
J Card Fail
|
2009
|
0.84
|
|
81
|
Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography.
|
J Am Soc Echocardiogr
|
2009
|
0.84
|
|
82
|
NOX5 expression is increased in intramyocardial blood vessels and cardiomyocytes after acute myocardial infarction in humans.
|
Am J Pathol
|
2012
|
0.84
|
|
83
|
Effects of alcohol septal ablation on coronary microvascular function and myocardial energetics in hypertrophic obstructive cardiomyopathy.
|
Am J Physiol Heart Circ Physiol
|
2011
|
0.83
|
|
84
|
Cardiovascular magnetic resonance imaging in patients with acute myocardial infarction.
|
Heart
|
2010
|
0.83
|
|
85
|
Carotid artery intima-media thickness, but not coronary artery calcium, predicts coronary vascular resistance in patients evaluated for coronary artery disease.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.83
|
|
86
|
Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).
|
Trials
|
2012
|
0.82
|
|
87
|
Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging.
|
J Cardiovasc Magn Reson
|
2004
|
0.82
|
|
88
|
Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between cardiac MRI and PET.
|
J Nucl Med
|
2005
|
0.82
|
|
89
|
The use of cardiac magnetic resonance imaging to determine the aetiology of left ventricular disease and cardiomyopathy.
|
Heart
|
2008
|
0.82
|
|
90
|
Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome.
|
Heart Rhythm
|
2010
|
0.81
|
|
91
|
Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study.
|
Radiology
|
2014
|
0.81
|
|
92
|
Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: a PET and MRI study.
|
J Nucl Cardiol
|
2006
|
0.81
|
|
93
|
Impact of scar on water-perfusable tissue index in chronic ischemic heart disease: Evaluation with PET and contrast-enhanced MRI.
|
Mol Imaging Biol
|
2006
|
0.80
|
|
94
|
Effect of cardiac hybrid ¹⁵O-water PET/CT imaging on downstream referral for invasive coronary angiography and revascularization rate.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
0.80
|
|
95
|
Impact of alcohol septal ablation on left anterior descending coronary artery blood flow in hypertrophic obstructive cardiomyopathy.
|
Int J Cardiovasc Imaging
|
2009
|
0.80
|
|
96
|
Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial.
|
JACC Cardiovasc Interv
|
2011
|
0.80
|
|
97
|
Determinants of myocardial energetics and efficiency in symptomatic hypertrophic cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.80
|
|
98
|
The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
|
Eur J Clin Invest
|
2010
|
0.80
|
|
99
|
Effect of additional treatment with EXenatide in patients with an Acute Myocardial Infarction (EXAMI): study protocol for a randomized controlled trial.
|
Trials
|
2011
|
0.80
|
|
100
|
Relation between three-dimensional echocardiography derived left ventricular volume and MRI derived circumferential strain in patients eligible for cardiac resynchronization therapy.
|
Int J Cardiovasc Imaging
|
2008
|
0.80
|
|
101
|
Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy.
|
Int J Cardiovasc Imaging
|
2014
|
0.79
|
|
102
|
Positive predictive value of computed tomography coronary angiography in clinical practice.
|
Int J Cardiol
|
2010
|
0.79
|
|
103
|
Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury.
|
Am J Cardiol
|
2011
|
0.79
|
|
104
|
Parametric imaging of myocardial viability using ¹⁵O-labelled water and PET/CT: comparison with late gadolinium-enhanced CMR.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.79
|
|
105
|
Revascularization in patients with chronic ischaemic myocardial dysfunction: insights from cardiovascular magnetic resonance imaging.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.79
|
|
106
|
The effect of left bundle branch block on left ventricular remodeling, dyssynchrony and deformation of the mitral valve apparatus: an observational cardiovascular magnetic resonance imaging study.
|
Int J Cardiovasc Imaging
|
2006
|
0.78
|
|
107
|
NOX2, p22phox and p47phox are targeted to the nuclear pore complex in ischemic cardiomyocytes colocalizing with local reactive oxygen species.
|
Cell Physiol Biochem
|
2011
|
0.78
|
|
108
|
A meta-analysis of left ventricular dyssynchrony assessment and prediction of response to cardiac resynchronization therapy by three-dimensional echocardiography.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.78
|
|
109
|
Impaired hyperemic myocardial blood flow is associated with inducibility of ventricular arrhythmia in ischemic cardiomyopathy.
|
Circ Cardiovasc Imaging
|
2013
|
0.78
|
|
110
|
The effect of a comprehensive lifestyle intervention on cardiovascular risk factors in pharmacologically treated patients with stable cardiovascular disease compared to usual care: a randomised controlled trial.
|
BMC Cardiovasc Disord
|
2012
|
0.78
|
|
111
|
Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
|
J Cardiovasc Magn Reson
|
2007
|
0.78
|
|
112
|
3.0 T cardiovascular magnetic resonance in patients treated with coronary stenting for myocardial infarction: evaluation of short term safety and image quality.
|
Int J Cardiovasc Imaging
|
2007
|
0.77
|
|
113
|
Stroke volume measurements with first-pass dynamic positron emission tomography: comparison with cardiovascular magnetic resonance.
|
J Nucl Cardiol
|
2008
|
0.77
|
|
114
|
Effects of QRS duration and pacing location on pressure-volume loop evaluation of cardiac resynchronization therapy in end-stage heart failure.
|
Am J Cardiol
|
2011
|
0.77
|
|
115
|
Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy.
|
Circulation
|
2007
|
0.77
|
|
116
|
Assessment of coronary artery bypass graft disease using cardiovascular magnetic resonance determination of flow reserve.
|
J Am Coll Cardiol
|
2002
|
0.77
|
|
117
|
Basal infarct location but not larger infarct size is associated with a successful outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: a cardiovascular magnetic resonance imaging study.
|
Int J Cardiovasc Imaging
|
2015
|
0.76
|
|
118
|
Value and limitations of electromechanical endocardial mapping in the assessment of global and regional left ventricular function and transmural extent of infarction: a comparison with cardiovascular magnetic resonance.
|
EuroIntervention
|
2010
|
0.76
|
|
119
|
Reappraisal of a single-tissue compartment model for estimation of myocardial oxygen consumption by [11C]acetate PET: an alternative to conventional monoexponential curve fitting.
|
Nucl Med Commun
|
2011
|
0.76
|
|
120
|
Comparison of three-dimensional echocardiographic software packages for assessment of left ventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.76
|
|
121
|
High-pitch prospective ECG-triggered helical coronary computed tomography angiography in clinical practice: image quality and radiation dose.
|
Int J Cardiovasc Imaging
|
2014
|
0.76
|
|
122
|
A more detailed view calls for more detailed definition: description of cardiac morphology with high-resolution CT and MRI.
|
AJR Am J Roentgenol
|
2008
|
0.75
|
|
123
|
Non-compaction: a distinct cardiomyopathy or non-specific morphological trait?
|
Eur Heart J
|
2008
|
0.75
|
|
124
|
The failing heart.
|
N Engl J Med
|
2007
|
0.75
|
|
125
|
Arrhythmogenic right ventricular cardiomyopathy with evidence of biventricular involvement.
|
CMAJ
|
2007
|
0.75
|
|
126
|
Risk stratification for ventricular arrhythmias in ischaemic cardiomyopathy: the value of non-invasive imaging.
|
Europace
|
2010
|
0.75
|
|
127
|
Role of magnetic resonance imaging in arrhythmogenic right ventricular cardiomyopathy.
|
Am Heart J
|
2008
|
0.75
|
|
128
|
3D velocity quantification in the heart: improvements by 3D PC-SSFP.
|
J Magn Reson Imaging
|
2009
|
0.75
|
|
129
|
Unusual variation in upper-body venous anatomy found with cardiovascular MRI.
|
CMAJ
|
2006
|
0.75
|
|
130
|
Left ventricular remodeling after acute myocardial infarction: the influence of viability and revascularization - an echocardiographic substudy of the VIAMI-trial.
|
Trials
|
2014
|
0.75
|
|
131
|
Magnetic resonance imaging versus Doppler guide wire in the assessment of coronary flow reserve in patients with coronary artery disease.
|
Coron Artery Dis
|
2002
|
0.75
|
|
132
|
Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.75
|
|
133
|
Measurement of LV Volumes and Function Using Oxygen-15 Water-Gated PET and Comparison With CMR Imaging.
|
JACC Cardiovasc Imaging
|
2016
|
0.75
|
|
134
|
Three-dimensional magnetic resonance coronary angiography using a new blood pool contrast agent: initial experience.
|
J Cardiovasc Magn Reson
|
2002
|
0.75
|
|
135
|
Pericardial cyst.
|
Lancet
|
2005
|
0.75
|
|
136
|
A recurring valvular vegetation.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.75
|
|
137
|
Extrinsic multiecho phase-contrast SSFP: evaluation on cardiac output measurements.
|
Magn Reson Imaging
|
2008
|
0.75
|
|
138
|
Images in cardiovascular medicine. Coronary collaterals in full effect.
|
Circulation
|
2006
|
0.75
|
|
139
|
Evaluation of myocardial blood flow and coronary flow reserve after implantation of a bioresorbable vascular scaffold versus metal drug-eluting stent: an interim one-month analysis of the VANISH trial.
|
EuroIntervention
|
2016
|
0.75
|
|
140
|
Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
|
J Card Fail
|
2011
|
0.75
|
|
141
|
Imaging highlights from the European Association of Echocardiography and the Society of Cardiovascular Magnetic Resonance.
|
JACC Cardiovasc Imaging
|
2008
|
0.75
|
|
142
|
Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time, is associated with short and long term cardiac function.
|
EuroIntervention
|
2017
|
0.75
|
|
143
|
Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: pilot of the Sonolysis study.
|
Ultrasound Med Biol
|
2011
|
0.75
|
|
144
|
Prediction of functional recovery after revascularization in patients with chronic ischemic myocardial dysfunction: perfusable tissue index by positron emission tomography and contrast-enhanced MRI comparison study.
|
Nucl Med Commun
|
2011
|
0.75
|
|
145
|
Effects of Successful Percutaneous Coronary Intervention of Chronic Total Occlusions on Myocardial Perfusion and Left Ventricular Function.
|
EuroIntervention
|
2017
|
0.75
|